Clinical studies recruiting near Gilbert

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Banner MD Anderson Cancer Center ( Site 0001) · Merck Sharp & Dohme LLC · NCT04165070 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Ironwood Physicians P.C. dba Ironwood Cancer and Research Ce · Pfizer · NCT07028853 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Banner MD Anderson Cancer Center ( Site 0059) · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0167 · Bristol-Myers Squibb · NCT07106762 Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemi
NA · MD Anderson Cancer Center - Banner · M.D. Anderson Cancer Center · NCT02945579 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Takeda · NCT06671496 Selinexor and Backbone Treatments of Multiple Myeloma Patients
Phase 1/Phase 2 · Banner MD Anderson Cancer Center · Karyopharm Therapeutics Inc · NCT02343042 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Arizona Center for Cancer Care - Gilbert · NRG Oncology · NCT06532279 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327 Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · Banner Health - MD Anderson Cancer Center · Schrödinger, Inc. · NCT05544019 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Banner MD Anderson Cancer Center · Kura Oncology, Inc. · NCT07007312 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Banner MD Anderson Cancer Center ( Site 0181) · Merck Sharp & Dohme LLC · NCT06623422 Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Phase 2 · Site 112 · Yarrow Bioscience, Inc. · NCT07682896 Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r
Phase 1 · Banner MD Anderson Cancer Center · Imugene Limited · NCT03666000 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Ironwood Cancer & Research Centers · Pfizer · NCT06629779 A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients
Phase 2 · Arizona Arthritis & Rheumatology Associates · Elevara Medicines Limited · NCT07409103 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · San Tan Allergy & Asthma- Site Number : 8400031 · Sanofi · NCT07290803 Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed
Phase 2 · Banner MD Anderson Cancer Center · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT06297226 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · Arizona Arthritis & Rheumatology Associates, P.C. - Gilbert · Merck Sharp & Dohme LLC · NCT07133633 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · NRG Oncology · NCT06748222 AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metasta
Phase 1/Phase 2 · Avenzo Therapeutics Recruiting Site · Avenzo Therapeutics, Inc. · NCT07038343 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Arizona Arthritis & Rheumatology Associates (AARA) - Gilbert · Crystalys Therapeutics · NCT07089888 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Mercy Gilbert Medical Center · Eli Lilly and Company · NCT07223593 Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Phase 1 · Banner MD Anderson Cancer Center · ImmunoGenesis · NCT06014502 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Banner MD Anderson Cancer Center · Eli Lilly and Company · NCT06119581 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Mercy Gilbert Medical Center · Novartis Pharmaceuticals · NCT07517263 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1247 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · National Cancer Institute (NCI) · NCT06498635 A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Dise
Phase 3 · Gilbert Neurology Partners/CCT Research · Bristol-Myers Squibb · NCT06947941

Look up another city

Look up another condition